News

SEC Filings

Document Details

Form
Filing Date
October 11, 2019
Document Date
October 9, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
COLUMN GROUP III GP, LP

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com